MindRank Announces $52 Million Series B Financing
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER RIGHT
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
1.00 · RIGHT
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.500 · CENTER RIGHT
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.024
2,655 articles tracked
7-day bias trend
LcenterR
Article Excerpt
Funding to advance MindRank’s AI-native drug R&D engine and innovative pipeline, including MDR-001, an oral small-molecule GLP-1 receptor agonist in Phase III clinical development in China HANGZHOU, China, July 09, 2026 (GLOBE NEWSWIRE) — MindRank AI Ltd. (“MindRank”), a clinical-stage biotechnology company dedicated to building an AI-native engine for drug research and development, today announced […]
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Jul 10, 2026